NS · Pharmaceuticals
Pharmaceuticals & Biotechnology
Indoco Remedies Ltd (INDOCO) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $21.88B, P/E ratio is -388.52, net margin is 1.9%, dividend yield is 0.08%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Indoco Remedies Ltd (INDOCO) has a reported market cap of $21.88B (data as of 2026-07-10).
The price-to-earnings (P/E) ratio for Indoco Remedies Ltd (INDOCO) is -388.52 (data as of 2026-07-10).
Indoco Remedies Ltd (INDOCO) shows a reported dividend yield of 0.08%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).
Indoco Remedies Ltd (INDOCO) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
INDOCO is listed on NS.
Indoco Remedies Ltd (INDOCO) reports a net margin of 1.9% (data as of 2026-07-10).
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.